NIH prepares for surge in whole-genome sequencing

The medical community needs a plan for handling the fast-growing knowledge about the health risks identified through whole-genome sequencing, said National Institutes of Health (NIH) Director Francis Collins, MD, PhD.

“I’m going to argue that we really need to have a plan about how we will handle that [information] when the preferred test is not this gene, plus that gene, plus the other gene, but is the whole genome,” said Collins, a renowned geneticist who helped lead the Human Genome Project. “We are at an inflection point, and we ought to think very carefully about — not today — but 3 or 4 years from now about how we prepare for what’s going to be extremely exciting.”

Read the full, original story here: NIH Chief: Get Ready for Testing Whole Genome

{{ reviewsTotal }}{{ options.labels.singularReviewCountLabel }}
{{ reviewsTotal }}{{ options.labels.pluralReviewCountLabel }}
{{ options.labels.newReviewButton }}
{{ userData.canReview.message }}
screenshot at  pm

Are pesticide residues on food something to worry about?

In 1962, Rachel Carson’s Silent Spring drew attention to pesticides and their possible dangers to humans, birds, mammals and the ...
glp menu logo outlined

Newsletter Subscription

* indicates required
Email Lists
glp menu logo outlined

Get news on human & agricultural genetics and biotechnology delivered to your inbox.